Levocetirizine Dihydrochloride NEW
| Price | $43 | $78 | $133 |
| Package | 10mg | 25mg | 50mg |
| Min. Order: | |
| Supply Ability: | 10g |
| Update Time: | 2025-04-27 |
Product Details
| Product Name: Levocetirizine Dihydrochloride | CAS No.: 130018-87-0 |
| Purity: 99.75% | Supply Ability: 10g |
| Release date: 2025/04/27 |
Product Introduction
Bioactivity
| Name | Levocetirizine Dihydrochloride |
| Description | Levocetirizine Dihydrochloride (Xyzal Dihydrochloride) is a third-generation peripheral H1-receptor antagonist. Acting as an antihistaminic agent, it specifically targets the histamine H1-receptor. Levocetirizine Dihydrochloride is the R-enantiomer of Cetirizine, which gives it a higher affinity for the H1-receptor than the S-enantiomer. Due to this enhanced affinity, Levocetirizine Dihydrochloride is effective in treating allergic rhinitis and chronic idiopathic urticaria. |
| In vivo | Levocetirizine (0.4 mg/kg; oral administration; male Sprague-Dawley rats) yields a Cmax of 0.34 μg/mL, an AUC0-t of 3.26 μg h/mL, an AUC0-∞ of 3.67 μg h/mL, and a t1/2 of 2.34 hours in Sprague-Dawley rats[1]. |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
| Solubility Information | H2O : 90 mg/mL (194.9 mM), Sonication is recommended. DMSO : 50 mg/mL (108.27 mM), Sonication is recommended. |
| Keywords | Xyzal | Levocetirizine Dihydrochloride | Levocetirizine | HistamineReceptor | Histamine Receptor | H1 receptor | Cetirizine Dihydrochloride | Cetirizine |
| Inhibitors Related | Chlorphenesin | Histamine dihydrochloride | Meclizine dihydrochloride | Mirtazapine | Lidocaine | Famotidine | Mebhydrolin napadisylate | Sodium butanoate | Amitriptyline hydrochloride | Alginic acid | Trazodone hydrochloride | Mianserin hydrochloride |
| Related Compound Libraries | Bioactive Compound Library | Pain-Related Compound Library | Membrane Protein-targeted Compound Library | Anti-Cancer Clinical Compound Library | Drug Repurposing Compound Library | Inhibitor Library | FDA-Approved Drug Library | Anti-Cancer Approved Drug Library | Immunology/Inflammation Compound Library | Bioactive Compounds Library Max | GPCR Compound Library | Anti-Cancer Drug Library |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
Recommended supplier
| Product name | Price | Suppliers | Update time | |
|---|---|---|---|---|
| $0.00/1kg |
VIP4Y
|
Wuhan Biocar Pharmacy CO.,Ltd.
|
2025-03-05 | |
| $18.00/10kg |
VIP2Y
|
Hebei Shengyang Water Conservancy Engineering Co., Ltd.
|
2024-05-10 | |
| $100.00/1kg |
Hebei Zhuanglai Chemical Trading Co.,Ltd
|
2024-04-24 | ||
| $0.00/1g |
airuikechemical co., ltd.
|
2024-04-07 | ||
| $50.00/1kg |
VIP5Y
|
Hebei Yanxi Chemical Co., Ltd.
|
2023-09-19 | |
| $50.00/1kg |
Henan Bao Enluo International TradeCo.，LTD
|
2023-08-01 | ||
| $0.00/1Kg |
VIP3Y
|
Changzhou Rokechem Technology Co., Ltd.
|
2023-07-06 | |
| $690.00/1KG |
VIP3Y
|
Wuhan Senwayer Century Chemical Co.,Ltd
|
2022-10-14 | |
| $40.00/1KG |
Hebei Anda Technology Co., LTD
|
2022-09-15 | ||
| $10.00/1kg |
Hebei Linwo New Material Technology Co., LTD
|
2022-06-28 |
United States- Since: 2011-01-07
- Address: 36 Washington Street, Wellesley Hill, MA
INQUIRY